Phenotypic variability in human skin mast cells

Experimental Dermatology

Volumn 25, Issue 6, 2016, Pages 434-439

  Babina, Magda ^a   Guhl, Sven ^a   Artuc, Metin ^a   Trivedi, Neil N ^b,c   Zuberbier, Torsten ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b SAN FRANCISCO VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Chymase; Degranulation; Histamine; IgE receptor; Mast cells; Tryptase

Indexed keywords

CALCIUM; CHYMASE; HISTAMINE; HISTIDINE DECARBOXYLASE; IONOPHORE; MESSENGER RNA; TRYPTASE; IMMUNOGLOBULIN E RECEPTOR; STEM CELL FACTOR RECEPTOR;

ADULT; ALLERGIC REACTION; ARTICLE; CELL ACTIVATION; CONTROLLED STUDY; EXPERIMENTAL DESIGN; FLOW CYTOMETRY; HISTAMINE BLOOD LEVEL; HISTAMINE RELEASE; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; MAST CELL; PHENOTYPIC VARIATION; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SKIN CELL; SKIN DISEASE; ADOLESCENT; BIOLOGICAL VARIATION; CHEMISTRY; CHILD; CYTOLOGY; ENZYMOLOGY; INFANT; NEWBORN; PRESCHOOL CHILD; SKIN;

ADOLESCENT; BIOLOGICAL VARIATION, POPULATION; CHILD; CHILD, PRESCHOOL; HISTAMINE; HUMANS; INFANT; INFANT, NEWBORN; MALE; MAST CELLS; PROTO-ONCOGENE PROTEINS C-KIT; RECEPTORS, IGE; SKIN;

EID: 84969759483     PISSN: 09066705     EISSN: 16000625     Source Type: Journal    
DOI: 10.1111/exd.12924     Document Type: Article

References (55)

1. Yosipovitch G, Papoiu A D. Curr Allergy Asthma Rep 2008: 8: 306-311.
2. Brown J M, Wilson T M, Metcalfe D D. Clin Exp Allergy 2008: 38: 4-18.
3. Galli S J, Tsai M. Nat Med 2012: 18: 693-704.
4. Theoharides T C, Valent P, Akin C. N Engl J Med 2015: 373: 163-172.
5. Kempkes C, Buddenkotte J, Cevikbas F et al. Role of PAR-2 in Neuroimmune Communication and Itch. In: Carstens E, Akiyama T, eds. Itch: Mechanisms and Treatment. Boca Raton (FL): 11, 2014.
6. Gilfillan A M, Beaven M A. Crit Rev Immunol 2011: 31: 475-529.
7. Navi D, Saegusa J, Liu F T. Clin Rev Allergy Immunol 2007: 33: 144-155.
8. Kawakami T, Ando T, Kimura M et al. Curr Opin Immunol 2009: 21: 666-678.
9. Kneilling M, Rocken M. Exp Dermatol 2009: 18: 488-496.
10. Galli S J, Tsai M. Eur J Immunol 2010: 40: 1843-1851.
11. Marichal T, Tsai M, Galli S J. Cancer Immunol Res 2013: 1: 269-279.
12. Irani A M, Schwartz L B. Allergy Proc 1994: 15: 303-308.
13. Forsythe P, Ennis M. Inflamm Res 2000: 49: 147-154.
14. Bischoff S C. Nat Rev Immunol 2007: 7: 93-104.
15. Andersson C K, Mori M, Bjermer L et al. Thorax 2009: 64: 297-305.
16. Ghannadan M, Baghestanian M, Wimazal F et al. J Invest Dermatol 1998: 111: 689-695.
17. Motakis E, Guhl S, Ishizu Y et al. Blood 2014: 123: e58-67.
18. Guhl S, Neou A, Artuc M et al. Exp Dermatol 2014: 23: 933-935.
19. FANTOM Consortium and the RIKEN PMI and CLST (DGT) et al. Nature 2014: 507: 462-470.
20. Andersson R, Gebhard C, Miguel-Escalada I et al. Nature 2014: 507: 455-461.
21. Babina M, Motakis E, Zuberbier T. Exp Rev Clin Immunol 2014: 10: 977-980.
22. Joshi A, Pooley C, Freeman T C et al. J Leukoc Biol 2015. pii: jlb.6TA1014-477RR. [Epub ahead of print]
23. Zuberbier T, Chong S U, Grunow K et al. J Allergy Clin Immunol 2001: 108: 275-280.
24. Babina M, Guhl S, Starke A et al. J Leukoc Biol 2004: 75: 244-252.
25. Guhl S, Stefaniak R, Strathmann M et al. J Invest Dermatol 2005: 124: 453-456.
26. Babina M, Schulke Y, Kirchhof L et al. Cell Mol Life Sci 2005: 62: 214-226.
27. Guhl S, Babina M, Neou A et al. Exp Dermatol 2010: 19: 845-847.
28. Guhl S, Lee H H, Babina M et al. J Neuroimmunol 2005: 163: 92-101.
29. Harvima I T, Karkola K, Harvima R J et al. Arch Dermatol Res 1989: 281: 231-237.
30. Kivinen P K, Kaminska R, Naukkarinen A et al. Exp Dermatol 2001: 10: 246-255.
31. Metcalfe D D. Blood 2008: 112: 946-956.
32. Lennartsson J, Ronnstrand L. Physiol Rev 2012: 92: 1619-1649.
33. Kraft S, Rana S, Jouvin M H et al. Int Arch Allergy Immunol 2004: 135: 62-72.
34. Potaczek D P, Kabesch M. Clin Exp Allergy 2012: 42: 852-871.
35. Guhl S, Artuc M, Zuberbier T et al. Exp Dermatol 2012: 21: 878-880.
36. Babina M, Guhl S, Motakis E et al. Mol Cell Endocrinol 2015: 406: 49-59.
37. Babina M, Rex C, Guhl S et al. Exp Dermatol 2006: 15: 530-537.
38. Schwanhausser B, Busse D, Li N et al. Nature 2011: 473: 337-342.
39. Trivedi N N, Tamraz B, Chu C et al. J Allergy Clin Immunol 2009: 124: 1099-105.e1-4.
40. Pfeufer A, Osterziel K J, Urata H et al. Am J Cardiol 1996: 78: 362-364.
41. Sharma S, Rajan U M, Kumar A et al. J Hum Genet 2005: 50: 276-282.
42. Ohtsu H, Tanaka S, Terui T et al. FEBS Lett 2001: 502: 53-56.
43. Nakazawa S, Sakanaka M, Furuta K et al. Eur J Immunol 2014: 44: 204-214.
44. Caughey G H. Immunol Rev 2007: 217: 141-154.
45. Pejler G, Abrink M, Ringvall M et al. Adv Immunol 2007: 95: 167-255.
46. Lippert U, Artuc M, Grutzkau A et al. J Invest Dermatol 2004: 123: 116-123.
47. Benyon R C, Lowman M A, Church M K. J Immunol 1987: 138: 861-867.
48. Lawrence I D, Warner J A, Cohan V L et al. J Immunol 1987: 139: 3062-3069.
49. MacGlashan D Jr. J Cell Biol 1989: 109: 123-134.
50. Havard S, Scola A M, Kay L J et al. Clin Exp Allergy 2011: 41: 378-388.
51. MacGlashan D W Jr. J Allergy Clin Immunol 2007: 119: 626-633.
52. Youssef L A, Schuyler M, Gilmartin L et al. J Immunol 2007: 178: 4584-4594.
53. Blank U, Madera-Salcedo I K, Danelli L et al. Front Immunol 2014: 5: 453.
54. Krohn I K, Sverrild A, Lund G et al. Scand J Immunol 2013: 78: 352-356.
55. Galli S J, Borregaard N, Wynn T A. Nat Immunol 2011: 12: 1035-1044.